Common Stock, Shares, Outstanding of REGENEREX PHARMA, INC. from 30 Nov 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
REGENEREX PHARMA, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Nov 2010 to 30 Sep 2025.
  • REGENEREX PHARMA, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 281,750,910, a 1.2% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

REGENEREX PHARMA, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 281,750,910 +3,315,000 +1.2% 30 Sep 2025 10-Q 17 Nov 2025 2025 Q2
Q2 2025 281,175,910 +2,920,000 +1% 30 Jun 2025 10-Q 14 Aug 2025 2024 Q1
Q1 2025 281,070,910 +2,845,000 +1% 31 Mar 2025 10-Q 17 Nov 2025 2025 Q2
Q4 2024 278,465,910 +520,000 +0.19% 31 Dec 2024 10-Q 07 Feb 2025 2024 Q3
Q3 2024 278,435,910 +520,000 +0.19% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q2
Q2 2024 278,255,910 +923,250 +0.33% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q1
Q1 2024 278,225,910 +1,113,250 +0.4% 31 Mar 2024 10-K 30 Jun 2025 2024 FY
Q4 2023 277,945,910 +833,250 +0.3% 31 Dec 2023 10-Q 05 Feb 2024 2023 Q3
Q3 2023 277,915,910 +803,250 +0.29% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q2
Q2 2023 277,332,660 +220,060 +0.08% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q1
Q1 2023 277,112,660 0 0% 31 Mar 2023 10-K 24 Jun 2024 2023 FY
Q4 2022 277,112,660 0 0% 31 Dec 2022 10-Q 24 Jan 2023 2022 Q3
Q3 2022 277,112,660 +150,000,000 +118% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q2
Q2 2022 277,112,600 +149,999,940 +118% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q1
Q1 2022 277,112,660 +150,000,000 +118% 31 Mar 2022 10-K 09 Jun 2023 2023 FY
Q4 2021 277,112,660 +150,000,000 +118% 31 Dec 2021 10-Q/A 03 Feb 2022 2021 Q3
Q3 2021 127,112,660 0 0% 30 Sep 2021 10-Q 01 Nov 2021 2021 Q2
Q2 2021 127,112,660 0 0% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q1
Q1 2021 127,112,660 0 0% 31 Mar 2021 10-K 28 Jun 2022 2022 FY
Q4 2020 127,112,660 0 0% 31 Dec 2020 10-Q 11 Feb 2021 2020 Q3
Q3 2020 127,112,660 0 0% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q2
Q2 2020 127,112,660 0 0% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q1
Q1 2020 127,112,660 0 0% 31 Mar 2020 10-K 23 Jun 2021 2020 FY
Q4 2019 127,112,660 0 0% 31 Dec 2019 10-Q 10 Feb 2020 2019 Q3
Q3 2019 127,112,660 0 0% 30 Sep 2019 10-Q 30 Oct 2019 2019 Q2
Q2 2019 127,112,660 0 0% 30 Jun 2019 10-Q/A 29 Jul 2019 2019 Q1
Q1 2019 127,112,660 0 0% 31 Mar 2019 10-K/A 11 Aug 2020 2019 FY
Q4 2018 127,112,660 +10,250,000 +8.8% 31 Dec 2018 10-Q 04 Feb 2019 2018 Q3
Q3 2018 127,112,660 -28,950,000 -19% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q2
Q2 2018 127,112,660 -28,950,000 -19% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q1
Q1 2018 127,112,660 -28,950,000 -19% 31 Mar 2018 10-K/A 11 Aug 2020 2019 FY
Q4 2017 116,862,660 31 Dec 2017 10-Q 08 Feb 2018 2017 Q3
Q3 2017 156,062,660 30 Sep 2017 10-Q 07 Nov 2017 2017 Q2
Q2 2017 156,062,660 30 Jun 2017 10-Q 07 Aug 2017 2017 Q1
Q1 2017 156,062,660 31 Mar 2017 10-K 21 Jun 2018 2017 FY
Q4 2014 156,412,660 +5,289,660 +3.5% 30 Nov 2014 10-K 03 Mar 2015 2014 FY
Q3 2014 156,412,660 31 Aug 2014 10-Q 20 Oct 2014 2014 Q3
Q2 2014 151,158,000 31 May 2014 10-Q 23 Jul 2014 2014 Q2
Q1 2014 151,133,000 28 Feb 2014 10-Q 11 Apr 2014 2014 Q1
Q4 2013 151,123,000 +2,045,000 +1.4% 30 Nov 2013 10-K 03 Mar 2015 2014 FY
Q4 2012 149,078,000 -21,945,000 -13% 30 Nov 2012 10-K 28 Feb 2014 2013 FY
Q3 2012 146,053,000 -24,947,000 -15% 31 Aug 2012 10-Q 15 Oct 2012 2012 Q3
Q4 2011 171,023,000 +170,927,000 30 Nov 2011 10-K/A 28 Feb 2013 2012 FY
Q3 2011 171,000,000 31 Aug 2011 10-Q 13 Oct 2011 2011 Q3
Q4 2010 96,000* 30 Nov 2010 10-K 28 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.